Amelparib

N/A

Report date: 2026/04/08 15:31:47
NME

Base Information

Drug NameAmelparib
Drug Alias NameJI-6289JPI-289OJP3101OJP-3101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 inhibitors
TargetsPoly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsIschemic StrokeMyocardial InfarctionStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJeil Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMyocardial Infarction
Inactive IndicationsIschemic StrokeStroke

Other Information

ATC CodeN/A
Related LinksN/A